Amedisys, Inc.
AMED
$100.99
$0.010.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 85.63M | 89.84M | 43.23M | 82.93M | 91.98M |
| Total Depreciation and Amortization | 61.75M | 61.19M | 60.46M | 59.31M | 58.38M |
| Total Amortization of Deferred Charges | 938.00K | 991.00K | 991.00K | 991.00K | 991.00K |
| Total Other Non-Cash Items | 37.63M | 37.18M | 77.09M | 41.54M | 49.89M |
| Change in Net Operating Assets | 53.49M | 35.31M | 39.90M | 26.92M | -105.00M |
| Cash from Operations | 239.43M | 224.52M | 221.67M | 211.70M | 96.23M |
| Capital Expenditure | -4.41M | -5.10M | -6.55M | -7.33M | -6.93M |
| Sale of Property, Plant, and Equipment | 19.00K | 15.00K | -- | 36.00K | 36.00K |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | 0.00 | 0.00 |
| Other Investing Activities | -1.63M | -1.59M | -1.81M | -1.83M | -831.00K |
| Cash from Investing | -6.02M | -6.67M | -8.36M | -9.12M | -7.73M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -38.53M | -38.16M | -37.36M | -36.63M | -33.40M |
| Issuance of Common Stock | 458.00K | 402.00K | 309.00K | 88.00K | 873.00K |
| Repurchase of Common Stock | -7.96M | -8.40M | -6.15M | -6.96M | -7.24M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.43M | -7.52M | -5.72M | -7.64M | -2.54M |
| Cash from Financing | -53.46M | -53.67M | -48.92M | -51.14M | -42.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 179.95M | 164.18M | 164.38M | 151.43M | 46.20M |